FDA Approves Kadcyla for Breast Cancer

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2013-030
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

FDA Approves Test for TB

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
1997English

FDA Approves First Biosimilar to Treat Cancer

Cancer Discovery
Oncology
2017English

FDA Approves Breakthrough Immunotherapy for Patients With Non-Small-Cell Lung Cancer

Cancer
Cancer ResearchOncology
2017English

FDA Approves New Drug to Reduce Risk of Stroke

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

FDA Approves Second Vaccine to Protect Children Against Rotaviruses

Microbe
Microbiology
2008English

FDA-approves the First Therapy in 2018 for the Seizures Associated With Dravet Syndrome

NeuroPharmac Journal
2019English

Acellular Dermal Matrix, the Breast and the FDA.

Plastic and Reconstructive Surgery
Surgery
2020English

Identification of FDA-approved Drugs Targeting Breast Cancer Stem Cells Along With Biomarkers of Sensitivity

Scientific Reports
Multidisciplinary
2013English

MRS Council Approves Headquarters Building

MRS Bulletin
Materials ScienceTheoretical ChemistryCondensed Matter PhysicsPhysical
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy